Search

Author/Creator Chen, Christine I.

1. A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL). Issue 4 (21st March 2019)

Authors:
Chen, Christine I.; Paul, Harminder; Snitzler, Susi; Kakar, Sumeet; Le, Lisa W.; Wei, Ellen N.; Lau, Anthea; Johnston, James B.; Gibson, Spencer B.; Queau, Michelle; Spaner, David; Croucher, Danielle; Sherry, Barbara; Trudel, Suzanne
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 4(2019)
Page Start:
980
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL)*. Issue 1 (2nd January 2019)

Authors:
Chen, Christine I.; Paul, Harminder; Le, Lisa W.; Wei, Ellen N.; Snitzler, Susi; Wang, Trina; Levina, Olga; Kakar, Sumeet; Lau, Anthea; Queau, Michelle; Johnston, James B.; Smith, Deborah A.; Trudel, Suzanne
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 1(2019)
Page Start:
92
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. An open-label, pharmacokinetic study of lenalidomide and dexamethasone therapy in previously untreated multiple myeloma (MM) patients with various degrees of renal impairment – validation of official dosing guidelines. Issue 8 (2nd July 2020)

Authors:
Chen, Christine I.; Cao, Yanshuo; Trudel, Suzanne; Reece, Donna E.; Kukreti, Vishal; Tiedemann, Rodger; Prica, Anca; Paul, Harminder; Le, Lisa W.; Levina, Olga; Kakar, Sumeet; Lau, Anthea; Chen, Hongzhuan; Chen, Eric
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 8(2020)
Page Start:
1860
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents. (15th June 2013)

Authors:
Chen, Christine I.; Masih‐Khan, Esther; Jiang, Haiyan; Rabea, Ahmed; Cserti‐Gazdewich, Christine; Jimenez‐Zepeda, Victor H.; Chu, Chia‐Min; Kukreti, Vishal; Trudel, Suzanne; Tiedemann, Rodger; Tsang, Richard; Reece, Donna E.
Journal:
British journal of haematology
Issue:
Volume 162:Number 4(2013:Aug.)
Page Start:
483
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Long‐term follow‐up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia. (24th February 2014)

Authors:
Chen, Christine I.; Paul, Harminder; Wang, Trina; Le, Lisa W.; Dave, Nimisha; Kukreti, Vishal; Nong Wei, Ellen; Lau, Anthea; Bergsagel, Peter Leif; Trudel, Suzanne
Journal:
British journal of haematology
Issue:
Volume 165:Number 5(2014:Jun.)
Page Start:
731
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment. Issue 4 (30th September 2022)

Authors:
Baljevic, Muhamed; Gasparetto, Cristina; Schiller, Gary J.; Tuchman, Sascha A.; Callander, Natalie S.; Lentzsch, Suzanne; Monge, Jorge; Kotb, Rami; Bahlis, Nizar J.; White, Darrell; Chen, Christine I.; Sutherland, Heather J.; Madan, Sumit; LeBlanc, Richard; Sebag, Michael; Venner, Christopher P.;...
Journal:
EJHaem
Issue:
Volume 3:Issue 4(2022)
Page Start:
1270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗